Article Highlights Positive Study Results Presented at AAN Annual Meeting

By Mary Beth Nierengarten
CHICAGO, April 1, 2024

Ecopipam reduced the number of tics and the level of daily interference they cause in children and adolescents with Tourette syndrome, according to the results of a re-analysis of the phase 2b D1AMOND study presented in April at the AAN Annual Meeting in Denver.

“If this finding is confirmed in future studies, we could tell kids and their parents that this medication cuts down on both the number of different tics and how much they interfere on a daily basis,” said Donald L. Gilbert, MD, FAAN, professor of pediatrics and neurology at Cincinnati Children’s Hospital Center, who presented the findings.

Read More…